The 7 most recent market catalysts affecting $INBS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 15, 2026
Corporate Catalyst
Neutral
Impact 55
Intelligent Bio Solutions Registers 6,211,809 Shares Of Common Stock For Resale Underlying Warrants
Intelligent Bio Solutions (INBS) has filed an 8-K to register 6,211,809 shares of common stock for resale. These shares are tied to warrants issued in a September Private Placement…
Sep 1, 2026
Corporate Catalyst
Neutral
Impact 75
Intelligent Bio Solutions Commences ~$M Placement Of Common Shares, Warrants At Combined Price Of $2.455 Per Share
Intelligent Bio Solutions (INBS) has secured approximately $5.0 million in gross proceeds through a private placement of common shares (or pre-funded warrants) and two series of wa…
Sep 1, 2026
Corporate Catalyst
Neutral
Impact 75
UPDATE: Intelligent Bio Solutions Commences ~$5M Placement Of Common Shares, Warrants At Combined Price Of $2.455 Per Share
Intelligent Bio Solutions (INBS) is raising approximately $5 million through a private placement of common stock and associated warrants to a single existing institutional investor…
Sep 1, 2026
Corporate Catalyst
Neutral
Impact 85
Intelligent Bio Solutions Reports 98.2% Accuracy In Codeine Study, Accelerates FDA 510(k) Submission To September 2026
Intelligent Bio Solutions reported highly positive results from its latest Method Comparison Study for its Intelligent Fingerprinting Drug Screening System, demonstrating 98.2% acc…
Aug 17, 2026
Corporate Catalyst
Bullish
Impact 75
Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action?
Intelligent Bio Solutions (INBS) announced its Intelligent Fingerprinting Drug Screening business secured recertification to the ISO 13485:2016 quality management system standard. …
Aug 5, 2026
Corporate Catalyst
Neutral
Impact 55
Intelligent Bio Solutions Completes Usability Study For Intelligent Fingerprinting Drug Screening System To Detect Opiate Codeine
Intelligent Bio Solutions (INBS) has completed a usability study for its Intelligent Fingerprinting Drug Screening System, specifically for the detection of opiate codeine. This is…
Jul 21, 2026
Corporate Catalyst
Neutral
Impact 65
Intelligent Bio Solutions Completes Precision Testing For Its Intelligent Fingerprinting Drug Screening System To Detect Opiate Codeine
Intelligent Bio Solutions (INBS) has completed precision testing for its Intelligent Fingerprinting Drug Screening System, specifically for detecting opiate codeine. This is a cruc…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.